Cell biologist, geneticist and fascinated by all things science 🦠 🔬 . @CZIScience program officer leading single cell tech & supporting @humancellatlas
Train and submit your model predictions for the OpenADMET Expansion challenge!! Lots of submissions already rolling in. Check out the webinar from @wpwalters, @barrybunin@huggingface et al for more info https://t.co/jd4JTexRkD
Today @AnthropicAI released PubMed integration for Claude. No hallucinations. Just real science, real data. As a beta tester, this has been a game changer—like having a supercharged research assistant. Here are 6 prompts that will transform how you search the literature. A 🧵
A scientist's guide to AI agents — how could they help your research? @Nature
👉 https://t.co/2foSFgEtwx
Enjoyed discussing this with @LizzieGibney. Great to see @ScientistTools featured, along with several ongoing projects in our group.
AI agents can accelerate discovery, but their true scientific value depends on how we evaluate and test them, an open challenge for the field
It’s time again for Cell Biology at Scale (CB@S), an annual gathering for researchers from diverse disciplines to share ideas on how new technologies can transform #cellbiology!
Co-hosted by #CZBiohubNY & @ChanZuckerberg.
Learn more and register:
https://t.co/JleiackGKO
Big Network news! #CZBiohubSF + #CZImagingInstitute will join forces to form a new Biohub aimed at developing groundbreaking imaging technologies to observe, measure, and understand biology like never before.
Learn more:
https://t.co/2ZGoG78IU4
It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis or other (non-LCH) histiocytic sarcomas cases.
I'm trying to understand non-surgical chemo and targeted therapy options, new pathology markers to better diagnose subtypes/treatments, and any data on progression in pediatric patients. Please feel free to share – I’m trying to cast a wide net due to the rarity of this condition and how little is known.
People can contact me directly at my first name (as written in my profile) at https://t.co/ubo0zQRMn0.
Very excited about this project as a model for partnership, opportunity to open up new fields of biology, and the provide critical data that advance models toward fundamental questions in cell biology. Stay tuned for progress!!!
“The Billion Cells Project will help clarify our understanding of the fundamental biology underpinning human health + disease while supercharging efforts at the intersection of AI & biology.” - @JCoolScience
Learn more about the project https://t.co/YaP800otuT
CZI recently announced an innovative new opportunity for GPU access. It's an exciting approach specifically aimed at supporting bold and ambitious problems that are bottlenecked on compute. Have a look and please apply or encourage others to do so! https://t.co/iQPveKuKk9
6/6 the future is 😎. Like great science efforts, the questions and technology opportunities outpace the immediate learnings. Looking across our grantee communities and internal roadmaps has me filled with excitement. Can't wait for the next waves of data, tech & models.
The @humancellatlas package in @Nature is a bright spot for me as we move toward the end of the year. I'm late to the party and really enjoyed watching all the buzz last week🎆! Congrats to all involved👏 The weekend allowed reflection on a few personal areas of excitement 🧵1/6
5/6 the papers in the package on ethics and equity shared a lot of work and thinking on best practices that can be generalized. More focus on engagement and inclusion are necessary for robust science and paving the way for future collaboration models.
Incredibly exciting and important work. Studies like this are pushing the limits of functional screen and absolutely represent a beacon for work in the years to come. Can't wait! Also, the liver is amazing:)
In collaboration with Reuben Saunders, @JswLab, and Xiaowei Zhuang, we are very excited to release Perturb-Multi: a platform for pooled multimodal genetic screens in intact mammalian tissue.
Check it out!
https://t.co/iJ8hi3ddz4
In collaboration with Reuben Saunders, @JswLab, and Xiaowei Zhuang, we are very excited to release Perturb-Multi: a platform for pooled multimodal genetic screens in intact mammalian tissue.
Check it out!
https://t.co/iJ8hi3ddz4